Literature DB >> 2117209

Surfactant abnormalities and adult respiratory failure.

W Seeger1, U Pison, R Buchhorn, U Obertacke, T Joka.   

Abstract

Surfactant abnormalities have been implicated in the development of the acute respiratory distress syndrome in adults. Experimental studies show that surfactant inhibition by protein-leak into the alveolar space is of major importance under these circumstances. Fibrin(ogen)-surfactant-interaction appears to contribute to disturbances of surfactant function with subsequent alveolar instability and ventilation-perfusion-mismatch. In a prospective study in severely injured patients, the surfactant in serially obtained bronchoalveolar lavage fluids was investigated. An early leakage of plasma proteins into the alveolar space was noted in those patients, who developed severe ARDS. Moreover, deterioration of surfactant function was markedly more pronounced in those patients than in trauma victims who developed only mild pulmonary dysfunction. In addition to the protein-leakage, a progressive decrease of the surfactant-specific dipalmitoyl-phosphatidylcholine was noted, significantly correlated with the deterioration of surfactant function and the severity of respiratory failure. In conclusion, experimental and clinical studies show surfactant abnormalities in the adult respiratory distress syndrome. Plasma protein-leakage and progressive alteration of alveolar type II surfactant secretion appear to be of major importance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117209     DOI: 10.1007/bf02718225

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  27 in total

1.  Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer.

Authors:  W Seeger; G Stöhr; H R Wolf; H Neuhof
Journal:  J Appl Physiol (1985)       Date:  1985-02

2.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

3.  Isolation and quantitative estimation of pulmonary surface-active lipoprotein.

Authors:  M E Abrams
Journal:  J Appl Physiol       Date:  1966-03       Impact factor: 3.531

4.  Surfactant abnormalities in patients with respiratory failure after multiple trauma.

Authors:  U Pison; W Seeger; R Buchhorn; T Joka; M Brand; U Obertacke; H Neuhof; K P Schmit-Neuerburg
Journal:  Am Rev Respir Dis       Date:  1989-10

5.  Pulmonary surface film stability and composition.

Authors:  J N Hildebran; J Goerke; J A Clements
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-09

6.  Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors.

Authors:  S C Afford; R A Stockley; J A Kramps; J H Dijkman; D Burnett
Journal:  Anal Biochem       Date:  1985-11-15       Impact factor: 3.365

7.  High-performance liquid chromatography of adult human bronchoalveolar lavage: assay for phospholipid lung profile.

Authors:  U Pison; E Gono; T Joka; U Obertacke; M Obladen
Journal:  J Chromatogr       Date:  1986-04-25

8.  Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome.

Authors:  P E Parsons; A A Fowler; T M Hyers; P M Henson
Journal:  Am Rev Respir Dis       Date:  1985-09

9.  Surfactant quantity and composition during recovery from hyaline membrane disease.

Authors:  J C Jackson; S Palmer; W E Truog; T A Standaert; J H Murphy; W A Hodson
Journal:  Pediatr Res       Date:  1986-12       Impact factor: 3.756

10.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

View more
  8 in total

Review 1.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

2.  Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome.

Authors:  Michael C Seeds; Bonnie L Grier; Bruce N Suckling; Anca M Safta; David L Long; B Moseley Waite; Peter E Morris; R Duncan Hite
Journal:  Am J Med Sci       Date:  2012-06       Impact factor: 2.378

Review 3.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 4.  Future developments in the pharmacotherapy of lung disease.

Authors:  A Van der Kuy
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

Review 5.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

Review 6.  Advances in the critical care of poisoned paediatric patients.

Authors:  W Banner; O D Timmons; D D Vernon
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

7.  Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.

Authors:  David Machado-Aranda; Zhengdong Wang; Bi Yu; M V Suresh; Robert H Notter; Krishnan Raghavendran
Journal:  Surgery       Date:  2012-07-31       Impact factor: 3.982

Review 8.  The surfactant system of the adult lung: physiology and clinical perspectives.

Authors:  H Hamm; H Fabel; W Bartsch
Journal:  Clin Investig       Date:  1992-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.